Definitive Contract 80NSSC25C0148

Award Date 9/29/25
Potential Completion Date 3/27/26
Potential Value $147K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
500
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $2,877,734 firm fixed-price definitive contract awarded by the National Aeronautics and Space Administration (NASA) Johnson Space Center to Auxilium Biotechnologies Inc., a for-profit manufacturer of goods. The contract tasks Auxilium to leverage microgravity aboard the International Space Station to biomanufacture implantable or injectable drug-delivery medical devices, such as through 3D bioprinting techniques. This contract award has no set-aside designation and is not associated...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Shared Services Center, a civilian federal agency, to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business located in College Station, Texas. The $156,491.00 Firm Fixed Price contract is for the development of a "Microgravity-Compatible Liquid-Free Surface Sampling Pen (SSP)," which is a specialized technology for sampling surfaces in microgravity environments. The...
This is a $1,700,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Air Force Research Laboratory (AFRL) to Critical Innovations LLC, a small business medical research and development company. The contract is for the development of a fully-qualified manufacturing system for the automated, on-demand, point-of-use production of qualified devices for use in space logistics support by Space Force end users. The contract is a firm-fixed-price purchase order with a...
The National Aeronautics and Space Administration (NASA) awarded a $125,000 Small Business Innovation Research (SBIR) Program Phase I contract to Ai Biosciences, Inc. to develop a microgravity-compatible, compact, and automated sample preparation platform. The platform is designed to process various sample types, including swabs, water, blood, and urine, to extract high-quality nucleic acids for rapid microbial identification, which can support crew safety on long-duration space missions. The...
The National Aeronautics and Space Administration (NASA) Shared Services Center awarded a $124,994.00 Firm Fixed Price contract to Ai Biosciences, Inc., a Minority Owned Business and Self Certified Small Disadvantaged Business, for the development of a Compact and Automated Liquid-Handling Robot for Microgravity Uses. This award is part of NASA's Small Business Innovation Research (SBIR) Program Phase I. The contract is set aside for Total Small Business participation and will be performed in...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Ambrosia Space Manufacturing Corporation, a small disadvantaged business, for the development of co-cultures for bench-scale beta-carotene production in microgravity. The contract has a ceiling value of $179,389.10 and a period of performance through October 31, 2025. This SBIR Phase I contract is part of AFRL's broader research and development efforts focused on...
<p>This is a $1,700,320.72 cost-plus-fixed-fee contract awarded by the U.S. Army Contracting Command (ACC) Aberdeen Proving Ground to Exicure, Inc., a small business concern, under the SBIR Phase II program. The contract is for research and development entitled &quot;Genetically Programmable Spherical Nucleic Acids as Rapidly Adaptable Nanotherapeutics&quot; and has a period of performance through January 31, 2016. This SBIR Phase II contract was set aside for small businesses.</p>
This is a $156,310 Firm Fixed Price, Phase I Small Business Innovation Research (SBIR) contract awarded by NASA's Shared Services Center to Infibertech, Corp, a small business Subchapter S corporation. The contract is for the development of a miniature, high-performance integrated photonics inertial measurement unit (IMU) and is set to be completed by February 6, 2025. This award is the third SBIR contract Infibertech has received from NASA, totaling over $1.02 million, as the company...
The National Aeronautics and Space Administration (NASA) awarded a $124,994.00 Firm Fixed Price contract to Ai Biosciences, Inc., a minority-owned small disadvantaged business, for the development of a compact and automated library preparation device for Nanopore sequencing under the SBIR Program Phase I. The contract is set aside for Total Small Business participation and will be performed in College Station, TX. Ai Biosciences is a biotechnology research company that specializes in...

The U.S. government has awarded a Small Business Innovation Research (SBIR) Phase I contract to Auxilium Biotechnologies Inc., a for-profit manufacturer of goods, for the SBIR I Auxilium Microfabrication Platform Cartridge Modification project. The firm fixed-price, definitive contract has a ceiling value of $146,794 and a completion date of March 27, 2026. Auxilium Biotechnologies is based in San Diego, California and has received prior federal grant funding for the development of nerve repair and neural interface technologies. This contract tasks Auxilium to leverage microgravity aboard the International Space Station to biomanufacture implantable or injectable drug-delivery medical devices, likely through techniques such as 3D bioprinting. The contract is set aside for small businesses.

Generated 9/13/25, 9:53 AM